Seeking efficiency in executive compensation benchmarking?

Unlock Efficiency in Executive Compensation Benchmarking with CompAnalyst Executive

CompAnalyst Executive

The charts on this page feature a breakdown of the total annual pay for the top executives at AXCELLA HEALTH INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. AXCELLA HEALTH INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. AXCELLA HEALTH INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Paul Fehlner J.D., Ph.D
Chief Legal Officer
Total Cash $549,260 Equity $86,215 Other $8,700 Total Compensation $644,175
Robert Crane
Former Senior Vice President and Chief Financial Officer
Total Cash $335,915 Equity $401,801 Other $8,202 Total Compensation $745,918
Margaret James Koziel M.D.
Former Senior Vice President and Chief Medical Officer
Total Cash $572,389 Equity $41,133 Other $7,380 Total Compensation $620,902
William R. Hinshaw Jr.
President and CEO
Total Cash $863,616 Equity $435,679 Other $8,061 Total Compensation $1,307,356
For its 2019 fiscal year, AXCELLA HEALTH INC, listed the following board members on its annual proxy statement to the SEC.
Catherine A. Sohn, PharmD. Total Cash $133,082
Cristina M. Rondinone, Ph.D. Total Cash $131,301
David A. Berry, M.D., Ph.D. Total Cash $128,801
David R. Epstein Total Cash $1,232,519
Gary Pisano, Ph.D. Total Cash $131,426
Gr"¦gory Behar Total Cash $131,426
Stephen Hoge, M.D. Total Cash $129,551
William D. Baird, III Total Cash $146,426

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.